Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jan 22.
Published in final edited form as: Anim Health Res Rev. 2014 Jan 8;15(1):63–75. doi: 10.1017/S1466252313000170

Shiga toxin-producing Escherichia coli in swine: the public health perspective

Marion Tseng 1,*, Pina M Fratamico 2, Shannon D Manning 3, Julie A Funk 1
PMCID: PMC4121380  NIHMSID: NIHMS608577  PMID: 24397985

Abstract

Shiga toxin-producing Escherichia coli (STEC) strains are food-borne pathogens that are an important public health concern. STEC infection is associated with severe clinical diseases in human beings, including hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS), which can lead to kidney failure and death. Cattle are the most important STEC reservoir. However, a number of STEC outbreaks and HUS cases have been attributed to pork products. In swine, STEC strains are known to be associated with edema disease. Nevertheless, the relationship between STEC of swine origin and human illness has yet to be determined. This review critically summarizes epidemiologic and biological studies of swine STEC. Several epidemiologic studies conducted in multiple regions of the world have demonstrated that domestic swine can carry and shed STEC. Moreover, animal studies have demonstrated that swine are susceptible to STEC O157:H7 infection and can shed the bacterium for 2 months. A limited number of molecular epidemiologic studies, however, have provided conflicting evidence regarding the relationship between swine STEC and human illness. The role that swine play in STEC transmission to people and the contribution to human disease frequency requires further evaluation.

Keywords: shiga toxin-producing Escherichia coli (STEC), swine, food safety

Introduction

Infection with Shiga toxin-producing Escherichia coli (STEC) is a critical public health concern. STEC infections are associated with outbreaks and sporadic cases of diarrhea and severe clinical diseases in human beings, including hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS) (Karmali et al., 1985; Nataro and Kaper, 1998). HUS is a life-threatening thrombotic disorder characterized by acute renal failure, thrombocytopenia and microangiopathic hemolytic anemia (Karmali et al., 1985; Karmali 1989; Tarr et al., 2005). It is one of the leading causes of acute renal failure in young children worldwide (Williams et al., 2002; Tarr et al., 2005; Karmali et al., 2010). Every year in the USA, more than 170,000 human illnesses are attributed to STEC (Scallan et al., 2011), and food-borne STEC illnesses represent an estimated economic burden of 280 million dollars (Hoffmann et al., 2012).

STEC represent a subset of E. coli that produce a cytotoxin known as the Shiga toxin (Stx), or verotoxin. Various STEC transmission routes have been identified, although STEC infections are most frequently associated with consumption of contaminated food (meat, dairy products, produce, and others) and water (Rangel et al., 2005; Doyle et al., 2006; Kaspar et al., 2010). Other sources of infection include animal contact (Durso et al., 2005; Keen et al., 2006, 2007), person-to-person contact (Spika et al., 1986; Carter et al., 1987; Rowe et al., 1993), and airborne transmission (Varma et al., 2003). Cattle have been suggested to be the important animal reservoir of STEC, and they do not typically present with any STEC-associated clinical symptoms (Griffin and Tauxe, 1991; Rangel et al., 2005; Gyles, 2007), except in calves under experimental conditions (Dean-Nystrom et al., 1997). Nevertheless, many other food products, including pork products, have been confirmed as vehicles of STEC transmission (CDC, 1995a, b; Paton et al., 1996; Williams et al., 2000; MacDonald et al., 2004; Conedera et al., 2007; Trotz-Williams et al., 2012). Feral swine, for example, were found to be a risk factor for STEC O157:H7 contamination of the spinach implicated in a 2006 North American outbreak (Jay et al., 2007). In pork-associated outbreaks and cases, it is unknown whether the contamination of pork products occurs during swine processing or via cross-contamination from other foodstuffs (Williams et al., 2000; MacDonald et al., 2004; Conedera et al., 2007; Trotz-Williams et al., 2012). Although swine-associated outbreaks have been reported less frequently than cattle-associated outbreaks, the likelihood that swine represent an important source of STEC infections in human beings cannot be overlooked.

The role that swine play in STEC transmission to human beings needs to be further evaluated to determine whether swine-derived STEC strains are an important public health concern. The severe symptoms associated with STEC infections and the increasing frequency of infections caused by a large variety of STEC serotypes highlight the fact that more research is needed to better understand these pathogens to aid in developing prevention and control strategies. In this literature review, previous studies focusing on STEC of swine origin will be critically summarized.

Food-borne outbreaks associated with pork products

Although only in a few instances, pork has been reported as a potential vehicle involved in outbreaks of STEC infections (CDC, 1995a, b; Paton et al., 1996; Williams et al., 2000; MacDonald et al., 2004; Conedera et al., 2007; Trotz-Williams et al., 2012). Table 1 summarizes the food products involved in these outbreaks and the serotype and virulence gene characteristics of the STEC strains isolated in these outbreaks. Mixed meat products were involved in most of these reported outbreaks. Thus, it was difficult to attribute the source of contamination to any of the animal species. Notably, the most recent outbreaks were associated with salami containing only pork (Conedera et al., 2007) and large cuts of pork from a whole roasted pig (Trotz-Williams et al., 2012). It is impossible to eliminate the possibility that cross-contamination from different foodstuffs took place during processing. However, pigs were suggested to be the source of STEC O157:H7 infection in the most recent outbreak (Trotz-Williams et al., 2012). Although the responsible source of STEC was not conclusive in these outbreaks, pork products cannot be excluded as a potential vehicle of STEC transmission.

Table 1.

Outbreaks associated with pork products

Outbreak location and year STEC serotype stx gene subtype eae gene Food product Reference
Washington and California, USA, 1994 O157:H7 Not specified Not specified Salami (mixed pork and beef) (CDC, 1995a)
Australia, 1995 O111:H- stx1, stx2 Positive Mettwurst (mixture of raw pork, beef, and lamb) (CDC, 1995b; Paton et al., 1996)
Ontario, Canada, 1998 O157:H7 Not specified Not specified Salami (mixed pork and beef) (Williams et al., 2000)
British Columbia, Canada, 1999 O157:H7 Not specified Not specified Salami (mixed pork and beef) (MacDonald et al., 2004)
Italy, 2004 O1 57: non-motile stx1, stx2 Positive Salami (pork only) (Conedera et al., 2007)
Ontario, Canada, 2011 O157:H7 Not specified Not specified Pork from a whole roasted pig (Trotz-Williams et al., 2012)

STEC prevalence in swine populations

Although outbreaks have been rarely reported, the incidence of human STEC outbreaks associated with pork products has raised questions about the sources of STEC in the food chain, from pork products, to pigs at slaughter facilities, to the most upstream origin: on-farm swine. The presence of STEC in pork or pork-associated products has been reported in some epidemiologic studies (Samadpour et al., 1994; Brooks et al., 2001; Jo et al., 2004; Oteiza et al., 2006; Xia et al., 2010; Ateba and Mbewe, 2011; Li et al., 2011). These data were sparse, and the numbers related to STEC prevalence in pork or pork-associated products were not consistent. The discrepancies are potentially attributable to multiple factors. For example, different isolation protocols and different types of pork products were used in these studies. In short, these positive findings of STEC in pork and pork-associated products indicate that STEC are present on retail pork products. The possibility that swine play a role in the contamination of pork products cannot be excluded.

The prevalence of STEC in clinically healthy swine populations has been reported in numerous studies in multiple regions of the world. In the USA, STEC detection in the swine population has been reported. A study was published in which colon samples were obtained from pigs at a US slaughter facility to detect the presence of STEC O157 (Feder et al., 2003). Six (1.9%) of the 305 colon samples were positive for STEC O157:H7. Interestingly, no STEC O157:H7 isolate was recovered in the National Animal Health Monitoring System’s (NAHMS) Swine 1995 study (Bush, 1997) and the later NAHMS 2000 study (Feder et al., 2007). However, it is impossible to directly compare the number of STEC O157:H7 positive samples in these studies due to different study designs and sample collection methods. In short, these reports provided evidence that swine in the USA carry STEC serotype O157:H7, although at a much lower rate compared with cattle.

Besides STEC O157:H7, the NAHMS 2000 study also recovered and characterized non-O157 STEC isolates (Fratamico et al., 2004, 2008). At least one STEC isolate was recovered from 196 (28.5%) of 687 fecal samples. A total of 219 STEC isolates were recovered, and they were categorized into various non-O157 O serogroups. Most importantly, some O serogroups had previously been associated with human clinical cases, namely O9, O20, O91, O101, and O121. The results of this study indicated that clinically healthy pigs from multiple states in the USA shed non-O157 STEC at some point during the late finishing period.

A recent study reported no significant effect of antimicrobials (chlorotetracycline and bacitracin) in feed on fecal shedding of non-O157 STEC in finishing swine (Wells et al., 2012). Notably, STEC belonging to important O serogroups, namely O26, O103, and O145, were isolated from 6.9, 2.4, and 4.8% of all the swine rectal swab samples. However, this study targeted a selected group of non-O157 STEC for detection in the samples (O26, O103, O111, O121, and O145). In spite of this approach, the high prevalence of the Shiga toxin gene (stx) in enriched samples (58% prior to slaughter) and the detection of non-O157 STEC belonging to important O serogroups highlight the need to further investigate STEC shed by clinically healthy swine.

Besides the USA, studies in other regions of the world reported wide ranging estimates of STEC prevalence from 0% (Oporto et al., 2008; Pinaka et al., 2013) to 68.3% (Borie et al., 1997). The highest prevalence, 68.3%, was reported from one study in Chile (Borie et al., 1997). Rectal swab samples were collected during the evisceration process from swine and cattle at slaughter facilities. Surprisingly, the STEC prevalence in swine samples was higher than that in cattle (28.7%). In addition to the strains identified as non-typable by O serogrouping, O157 was the most prevalent O serogroup among the swine STEC isolates. Other important STEC serogroups, such as O26 and O111, have also been reported (Rios et al., 1999). In one state in Brazil, the prevalence of STEC was 1.4% (one STEC-positive sample) from 74 fecal samples obtained aseptically from swine intestines at slaughter facilities (Martins et al., 2011). A later study performed in another state in Brazil reported one (0.4%) STEC O103 isolate recovered from 215 sponge-rubbed samples from swine carcasses at three slaughter facilities (Borges et al., 2012).

In a South African study, E. coli O157:H7 was more frequently found in swine fecal samples and in pork (67.7%) than in cattle fecal samples and beef (27.7%) (Ateba and Mbewe, 2011). In this study, only a selected subset of E. coli O157:H7 isolates was analyzed for the presence of stx. Therefore, it is difficult to determine the number of STEC O157:H7 positive samples in this study. Nevertheless, this study was in agreement with the previous Chilean studies (Borie et al., 1997; Rios et al., 1999) showing that swine are able to shed STEC at a relatively high rate and are potentially important STEC reservoirs in some places in the world.

Several European studies have reported STEC prevalence in swine populations, and most of the earlier studies focused on STEC serogroup O157. A study conducted in the UK reported the recovery of six (0.3%) STEC O157 isolates from over 2000 swine fecal samples at slaughter facilities (Milnes et al., 2009). Similarly, in Ireland, the prevalence of STEC O157:H7 was 0.6% (3 of 480) in fecal samples of pigs at slaughter facilities (Lenahan et al., 2009a). In a study conducted in the Netherlands, STEC O157 was isolated from 1 (0.7%) of 145 fecal samples from pigs at one slaughter facility (Heuvelink et al., 1999). A low proportion (0.7%, 1 of 150) of STEC O157-positive fecal samples was reported from pigs at slaughter facilities in Northern Italy (Bonardi et al., 2003). In Norway, STEC O157:H7 was found in 2 (0.1%) samples of intestinal contents from 1,976 pigs, and one of the two pigs was housed on a farm that also reared cattle. However, no STEC O157:H7 isolate was recovered from samples of cattle on the same farm (Johnsen et al., 2001). Interestingly, other studies also reported isolation of STEC O157:H7 strains from pigs that were kept with cattle or other ruminants on the same farm. For instance, STEC O157:H7 was recovered from 2 (0.08%) of 2,446 fecal samples of slaughtered pigs that were housed with ruminants on the same farm in a Swedish study (Eriksson et al., 2003). In general, the prevalence of STEC O157:H7 in swine appeared to be low in these studies. However, the presence of ruminants on the same farm that reared swine suggests that horizontal transmission of STEC may occur between different animal species.

Several studies investigated the prevalence of both STEC O157 and non-O157 in clinically healthy swine populations. A study in Belgium reported that non-O157 STEC strains were isolated from 8 (7.9%) out of 101 swine colon fecal samples at a slaughter facility (Botteldoorn et al., 2003). In Switzerland, the stx gene was detected in 138 (22%) of the 630 swine fecal samples at a slaughter facility. Subsequently, forty-five non-O157 STEC isolates were recovered from 45 randomly selected stx-gene-positive samples (Kaufmann et al., 2006). It was difficult to estimate the true prevalence of STEC in this study because not every stx-positive sample was analyzed for STEC isolates. These reports suggest that swine may be potential reservoirs of non-O157 STEC. In these studies, relatively low numbers of STEC isolates were recovered even though the numbers of stx-positive samples were high. This fact reflects the challenges of non-O157 STEC isolation. In contrast to the above positive findings, one study conducted in Northern Spain analyzed pooled rectal fecal samples from a total of 510 pigs, and the test results were negative for both O157 and non-O157 STEC (Oporto et al., 2008). Negative isolation of STEC in 106 swine fecal samples was also reported by a study conducted in Central Greece (Pinaka et al., 2013).

The presence of STEC in swine populations has also been documented in Asia. In Japan, the prevalence of STEC O157:H7 in clinically healthy on-farm swine was 1.4%, and this number was similar to the prevalence in Japanese cattle around the same time period (Nakazawa and Akiba, 1999). A later Japanese national surveillance report stated that STEC isolates were recovered from 32 (14%) of 179 swine fecal samples. Some strains belonged to the serotypes frequently associated with human diseases (Kijima-Tanaka et al., 2005). In Korea, only reports of STEC O157:H7 in swine have been published. One (0.3%) STEC O157:H7 isolate was recovered from 345 fecal samples from pigs at slaughter facilities and on farms (Jo et al., 2004). Two STEC O157:H7 isolates were recovered from fecal samples of pigs at slaughter facilities in another study (Kim et al., 2005). However, the prevalence was unknown because the total number of samples from pigs was not provided. In a recent report from Korea, one (0.3%) STEC O157 isolate was recovered from 291 swine fecal samples (Keum et al., 2010). In China, one study reported STEC isolates recovered from 10 (2.1%) of 487 rectal swabs from pigs at a slaughter facility in Hong Kong. The pigs were from a number of provinces in mainland China (Leung et al., 2001). Another study reported the prevalence of STEC in one swine breeding farm in mainland China. STEC O157 was detected in 8 (1.1%) of 720 fecal samples, while non-O157 STEC was isolated from 33 (4.6%) samples (Yan et al., 2011). STEC strains were isolated from 10 (6%) of 169 swine fecal samples obtained from a number of swine farms in one province in Vietnam (Kobayashi et al., 2003).

In addition to domestic swine, feral swine and wild boars have been suggested to play a role in STEC transmission. The most prominent evidence was obtained from a study that took place in the USA in 2006. Feral swine were suggested to be involved in the contamination of spinach, which was associated with a nationwide outbreak caused by STEC O157:H7. The outbreak strain was isolated from feral swine feces, which were collected directly on the spinach fields (Jay et al., 2007). Moreover, reports in other countries also indicated the presence of STEC in wild boars. STEC O157:H7 was found in 1 (1.4%) of 68 wild boars in Sweden (Wahlstrom et al., 2003). One Spanish study investigated the presence of STEC O157:H7 and non-O157 STEC in wild boars. STEC O157:H7 was detected in 7 (3.3%) and non-O157 STEC was detected in 11 (5.2%) fecal samples from 212 wild boars (Sánchez et al., 2010).

Human-animal contact is an important risk factor for STEC transmission, thus the presence of STEC in swine in zoos and petting zoos has also been investigated. No STEC O157 was detected in 45 pig fecal samples collected at US institutions accredited by the Association of Zoos and Aquariums (Keen et al., 2007). In contrast, STEC O157:H7 was recovered in 13 (1.2%) of 1,102 fecal samples from pigs in 19 county fairs in two states in the USA (Keen et al., 2006). In the UK, an epidemiologic study was conducted to detect the presence of STEC O157 in ‘open farms’ in which there is close contact with animals to attract the general public (Pritchard et al., 2009). STEC O157 was isolated in thirty (17.9%) of 168 swine fecal samples. However, this number may not reflect the true prevalence at one time point as it represents a collated number from samples collected from 22 different farms within a 10-year period. Moreover, it was not clear whether the pigs were housed together or in close contact with other animal species. Although the prevalence of STEC O157:H7 in these reports was low, pigs at facilities where direct contact with human beings may occur are another potential risk factor of STEC transmission.

In general, these data indicated that STEC strains in swine are geographically widely distributed given the fact that reports were from many regions in different continents. Although the prevalence numbers are wide ranging, these data provide epidemiologic evidence that STEC strains are prevalent in swine. Multiple factors may account for the discrepancies in the data among these studies, such as differences in farm management systems, sample sources, sampling methods, isolation protocols, and diagnostic tests used.

A number of reports have described detection of STEC O157 in swine fecal samples, and various non-O157 STEC serotypes were also detected in swine (Botteldoorn et al., 2003; Kaufmann et al., 2006; Fratamico et al., 2008). STEC belonging to various serogroups of which some that have been associated with human illness were identified in swine (Kaufmann et al., 2006; Fratamico et al., 2008), and, surprisingly, none of the serogroups were those commonly associated with swine edema disease. In addition, most of the above epidemiologic studies were cross-sectional studies, and they are unable to determine if the prevalence of STEC in swine changes with time (Dohoo et al., 2010). More research needs to be done to understand STEC shed by clinically healthy swine.

STEC in swine: edema disease

Besides isolation from clinically healthy swine, STEC can cause edema disease, which affects post-weaning pigs and young finishing pigs. Some STEC strains, in particular edema disease-associated STEC, also play a role in fatal shock, that occurs in pre- and post-weaning pigs (Fairbrother and Gyles, 2012). STEC strains belonging to certain serogroups, including O138, O139, O141, and O147 are more frequently associated with edema disease (Fairbrother and Gyles, 2012). These STEC strains colonize in the small intestine and typically produce the variant Shiga toxin 2e (Stx2e). The toxin enters the bloodstream and binds to the specific receptor, globotetrao-sylceramide (Gb4), which is located on epithelial and endothelial cells (DeGrandis et al., 1989). The toxin then impairs blood vessels, leading to edema, ataxia, and death (Fairbrother and Gyles, 2012). In general, the clinical presentations of swine edema disease are somewhat different from those associated with human STEC diseases.

Besides Stx2e, STEC strains associated with edema disease have been found to possess virulence factors different from those found in STEC strains isolated from human clinical cases. For example, F18 fimbriae are absent in most human-derived STEC (Sonntag et al., 2005), but are essential for adherence to swine epithelial cells (Bertschinger and Gyles, 1994), and therefore are likely to play a role in specificity and adaptation to the host. There are risk factors, including dietary changes and the introduction of pigs to new herds, suggested to be important for edema disease onset (Fairbrother and Gyles, 2012).

Human strains of Stx2e-producing E. coli

Interestingly, in addition to their isolation from pigs, Stx2e-producing E. coli strains were recovered from samples of wastewater treatment plants in France (Vernozy-Rozand et al., 2004), and from meat (pork, beef, wildlife) and milk in Germany (Beutin et al., 2007). Notably, although rarely documented, Stx2e-producing E. coli strains have been isolated from human patients with HUS (Thomas et al., 1994) and uncomplicated diarrhea (Pierard et al., 1991; Muniesa et al., 2000; Friedrich et al., 2002; Beutin et al., 2004; Sonntag et al., 2005). Moreover, Stx2e-producing E. coli strains have been recovered from stool samples of asymptomatic human beings (Friedrich et al., 2002; Sonntag et al., 2005). The etiologic role of Stx2e-producing E. coli strains in these human cases has not been determined. No particular source of infection has been identified in these human cases associated with Stx2e-producing E. coli.

A study was conducted to analyze Stx2e-producing E. coli strains from asymptomatic people, people with uncomplicated diarrhea, and diseased pigs to compare their virulence gene profiles and adherence to human and swine intestinal epithelial cells (Sonntag et al., 2005). Virulence genes commonly found in STEC strains associated with HC and HUS, such as the gene, eae, that encodes for intimin, an important attachment protein, were not detected in both the human- and swine-derived Stx2e-producing E. coli strains. This fact may suggest that unknown virulence factors are involved in the pathogenicity of human Stx2e-producing E. coli strains. Additionally, the human-derived Stx2e-producing E. coli strains adhered to human epithelial cells but not swine epithelial cells. In contrast, swine-derived Stx2e-producing E. coli strains lysed human epithelial cells and adhered to swine epithelial cells. This study only analyzed Stx2e-producing E. coli strains from diseased pigs, and thus, Stx2e-producing E. coli strains from healthy pigs need further examination.

Beutin et al., however, have characterized Stx2e-producing E. coli from people with uncomplicated diarrhea, people with no clinical symptoms, diseased pigs, and healthy pigs at slaughter facilities to determine their serotypes, distribution of virulence genes, and Stx2e production (Beutin et al., 2008). They found that Stx2e-producing E. coli strains from different sources were heterogeneous with regard to serotypes and virulence genes. In agreement with the results of Sonntag et al., (2005), virulence genes commonly detected in STEC strains associated with HC and HUS, such as eae and ehxA, the latter of which encodes an enterohemolysin, were not detected by PCR in both the human- and swine-derived Stx2e-producing strains analyzed in this study. Additionally, the authors used an enzyme immunoassay to find that human-derived strains produced significantly higher amounts of Stx2e than strains from diseased pigs. Interestingly, the toxin-production level did not significantly differ between strains from human subjects with uncomplicated diarrhea and those with no clinical symptoms. However, different environments (in hosts or under experimental conditions) may contribute to the differences of toxin production. Another likely explanation is that there are other unidentified virulence factors in the pathogenic Stx2e-producing E. coli strains.

In all of these reports, the primary conclusion was that there was a lack of evidence to suggest that Stx2e-producing E. coli strains are a critical public health concern. Nevertheless, these results also suggest that unknown virulence factors may contribute to the pathogenesis of Stx2e-producing E. coli strains in human hosts. Additionally, Stx2e-producing E. coli strains have been mostly isolated from human patients with uncomplicated diarrhea. Patients with uncomplicated diarrhea may not seek medical attention, which may contribute to the low reporting frequencies of Stx2e-producing E. coli infections in human patients. Some commercial serological tests do not detect the toxin Stx2e (Feng et al., 2011). The limitation of diagnostic tests may contribute to missed detection of Stx2e-producing E. coli infections. On the other hand, the picture remains unclear regarding the source of Stx2e-producing E. coli in human infections. More research is warranted to address whether there is an association between human Stx2e-producing E. coli strains and strains from pork, pigs, or the associated swine environment.

Molecular epidemiology of swine STEC

The presence of virulence genes other than stx also plays a role in the capability of STEC strains to cause disease (Bugarel et al., 2011). Therefore, examining the presence or absence of the selected virulence genes (virulence gene profile) is essential in assessing the public health risk of STEC strains (Cobbold and Desmarchelier, 2000; Slanec et al, 2009). A considerable challenge for understanding virulence gene profiles of swine STEC is that the profile of virulence genes targeted varies in each report. The most common virulence genes evaluated are stx1, stx2, eae, and ehxA. Different stx1, stx2, eae, and ehxA gene combinations have been detected in swine STEC strains (Borie et al., 1997; Feder et al., 2003). In the NAHMS 2000 study in the USA, although a majority of swine STEC strains carried the stx2e gene, 6% of the strains carried other stx2 variants. The eae gene was not detected in any of the swine isolates in this study (Fratamico et al., 2008), and this was in agreement with other studies (Leung et al., 2001; Kijima-Tanaka et al., 2005). In contrast, many studies have identified the eae gene in STEC strains from clinically healthy swine (Borie et al., 1997; Heuvelink et al., 1999; Nakazawa and Akiba, 1999; Johnsen et al., 2001; Bonardi et al., 2003; Botteldoorn et al., 2003; Feder et al., 2003; Jo et al., 2004; Kim et al., 2005; Kaufmann et al., 2006; Keen et al., 2006; Lenahan et al., 2009a; Ateba and Mbewe, 2011). Meanwhile, detection of the ehxA gene in swine STEC isolates was reported in numerous studies (Heuvelink et al., 1999; Botteldoorn et al., 2003; Kim et al., 2005; Chapman et al., 2006; Kaufmann et al., 2006; Fratamico et al., 2008; Lenahan et al., 2009a; Sánchez et al., 2010; Ateba and Mbewe, 2011). A limited number of studies described testing for different subsets of STEC virulence genes in swine STEC strains (Chapman et al., 2006; Zweifel et al., 2006; Fratamico et al., 2008; Lenahan et al., 2009a). For instance, some eae-negative swine STEC strains carried the saa gene (STEC autoagglutinating adhesion), and other adhesins (Chapman et al., 2006). The above studies suggest that swine STEC strains carry various combinations of virulence genes. A subset of swine STEC strains does carry important virulence genes in human pathogenesis, such as eae. More extensive examination is needed because the presence or absence of many other STEC virulence genes has not been examined in swine STEC strains.

Molecular genotyping methods, such as pulsedfield gel electrophoresis (PFGE), have been frequently utilized to evaluate the pathogenic potential of STEC strains and provide suggestions for future strategies in control and prevention of STEC transmission (Cobbold and Desmarchelier, 2001; Lanier et al., 2009). For example, these methods are used to identify the source of STEC during food-borne outbreaks and to determine the genetic relatedness of STEC strains (Barrett et al., 1994; Samadpour, 1995; Diekema et al., 1997; Izumiya et al., 1997; Singer et al., 2004). A limited number of studies have incorporated a small number of swine STEC strains to examine their genetic relatedness with strains from human subjects with diarrhea, HC, HUS, or without clinical symptoms (Franke et al., 1995; Rios et al., 1999; Johnsen et al., 2001; Lenahan et al., 2009b). Most of these studies focused on STEC O157:H7 strains, and only one study investigated STEC O101 strains (Franke et al., 1995). The results from these studies were inconsistent. One Chilean study indicated that the swine STEC O157 strains were categorized into the same cluster with strains from human HUS cases in the same geographic area by analyzing the PFGE patterns. However, no further epidemiologic relationship could be drawn between the swine isolates and human cases (Rios et al., 1999). One study conducted in Norway reported similarities of PFGE patterns among swine STEC O157:H7 strains and those isolated from human cases. However, there was no other epidemiologic information provided about the human STEC cases (Johnsen et al., 2001). In contrast, in an Irish study the investigators stated that swine STEC O157:H7 strains were not genetically related to human strains at the PFGE pattern similarity criterion of 80% (Lenahan et al., 2009b).

One study implemented repetitive element sequencebased PCR (rep-PCR) to examine the genetic relatedness of STEC O101 strains from swine and a human case of diarrhea. Interestingly, the result of the analysis indicated that swine STEC O101 strains showed a high degree of relatedness with the human STEC O101 strain. Moreover, the stx2e gene sequences from STEC O101 strains of two different origins shared a high degree of homology, and none of the STEC O101 strains carried the eae or ehxA genes (Franke et al., 1995). A direct relationship cannot be ascertained between the swine and human STEC since the strains were from two different countries and isolated in different time periods. However, the molecular evidence highlights that swine may be a potential STEC reservoir and a source of human infections.

A number of studies have examined the genetic relatedness of swine STEC strains to strains isolated from other animal reservoirs. The PFGE patterns indicated that swine STEC strains were not closely related to STEC strains of bovine origin (Rios et al., 1999; Lenahan et al., 2009b), ovine origin (Lenahan et al., 2009b) and from turkeys (Heuvelink et al., 1999). A Korean study demonstrated that swine STEC O157:H7 strains had distinct randomly amplified polymorphic DNA (RAPD) patterns compared with strains from cattle at a similarity criterion of 63% (Kim et al., 2005). Another study showed that swine STEC O157:H7 strains demonstrated some similarity in PFGE patterns to strains from cattle (Johnsen et al., 2001). A Polish study reported that one swine STEC O157 strain clustered with STEC O157 strains from cattle at a similarity criterion of 80% based on PFGE patterns. The swine STEC O157 strain was from a weaned pig with diarrhea, and no other epidemiologic relationship was described between the swine and cattle STEC strains (Osek and Gallien, 2002).

In the epidemiologic investigation following a spinach-associated outbreak of STEC O157:H7 in 2006 in the USA, PFGE and multilocus variable number tandem repeat analysis (MLVA) were used to analyze STEC isolates from different sources (Jay et al., 2007). Indistinguishable PFGE patterns from STEC isolates from cattle, feral swine, surface water, and soil were identified. MLVA also categorized the STEC isolates with indistinguishable PFGE patterns together with the outbreak STEC strain as one cluster. This evidence led the authors to suggest that feral swine may serve as a risk factor for STEC contamination of the spinach fields (Jay et al., 2007). Inspired by this outbreak, a Spanish study used PFGE to examine the genetic relatedness of STEC isolates from wild boar and a human patient with diarrhea (Sánchez et al., 2010). Surprisingly, a STEC isolate from a wild boar shared an indistinguishable PFGE pattern with a STEC isolate from a human patient with diarrhea in the same geographic area. Although there were no epidemiologic data available to establish a relationship between the human case and wild boar, the molecular genotyping results indicated that wild boars are a potential source of STEC contamination (Sánchez et al, 2010).

Results presented by these molecular epidemiologic studies are varied, which is potentially due to multiple factors. For example, there is potential selection bias of the isolates included in the genotypic analysis. Limited numbers of swine STEC strains and strains from other origins were included in the above molecular genotypic studies. The analytical results may not reflect the complete picture of genetic relatedness between STEC strains from swine and other origins. Moreover, most of the studies focused on STEC O157:H7. There is a paucity of knowledge on the genetic relatedness of non-O157 STEC from different origins. Conclusively, the genetic relationship of swine STEC strains with human clinical strains is still poorly understood. Filling these current knowledge gaps is relevant to not only better understand swine STEC but also to assess the potential public health risk of swine STEC.

The effect of swine STEC strains on human intestinal cells

Kennedy et al. (2010) infected human Caco-2 cells, which is a human colonic epithelial cell line, with STEC O157:H7 strains isolated from human patients or from healthy pigs at slaughter facilities. The human and swine STEC strains possessed the same virulence gene profiles, including eae and other virulence genes, published in an earlier study (Lenahan et al., 2009b). Notably, swine STEC O157:H7 strains induced greater loss of monolayer cell integrity than human-source STEC. Moreover, microarray experiments that examined RNA levels transcribed from different STEC genes indicated that swine and human STEC strains had different gene expression profiles. When exposed to swine STEC strains, expression levels of some genes involved in cytoskeleton rearrangement were up-regulated in the human Caco-2 cells (Kennedy et al., 2010). However, more research is needed to further examine the effect of infection with swine STEC strains on human epithelial cells.

STEC infection in swine: animal model studies

Swine have been used as an animal model in studies examining STEC colonization (Jordan et al., 2004), virulence of different STEC strains (Baker et al., 2007; Shringi et al., 2012), and treatment of STEC infections (Sheoran et al., 2005). Interestingly, some studies evaluated the pathogenicity and colonization of intiminnegative STEC strains in swine models. One study found that intimin-negative non-O157 STEC strains colonize and cause similar intestinal lesions and systemic diseases as intimin-positive STEC O157:H7 strains in cesarean-derived colostrum-deprived (CDCD) neonatal pigs (Dean-Nystrom et al., 2003). Moreover, a later study reported that there were no significant differences in bacterial counts and the numbers of tissues infected between intimin-positive and intimin-negative STEC O157:H7 strains in 12-week-old adult pigs (Jordan et al., 2005). Both intimin-positive and intimin-negative experimental strains were recovered in the pigs 38 days after inoculation. Notably, the result of this study in pigs is different from a previous study indicating that intimin aids the persistence of STEC O157:H7 strains in adult cattle and sheep (Cornick et al., 2002). This may suggest that other adhesins contribute to the colonization of STEC in swine. The above evidence demonstrates that swine are biologically capable of carrying STEC, including intiminpositive STEC strains.

To further understand if swine have the potential to become reservoirs of STEC, researchers have pursued experimental challenge models. Booher et al. inoculated 3-month-old pigs with mixtures of STEC O157:H7 and other pathogenic E. coli strains to observe the level and duration of fecal shedding (Booher et al., 2002). They reported that STEC O157:H7 strains were isolated from swine fecal samples up to 2 months after inoculation, and the experimental strains were recovered in swine intestinal tissues. Shedding of experimental STEC strains was dose-dependent, and strains inoculated at lower levels (107 CFU per strain per animal) were not recovered in the feces 2 months after inoculation. The dose-dependent shedding is similar to what was found in cattle under experimental conditions (Cray and Moon, 1995). Interestingly, one of the experimental strains inoculated at the lower dose was recovered in swine cecum tissues at necropsy 2 months after inoculation (Booher et al., 2002). This study suggested that swine could shed STEC O157:H7 for at least 2 months.

Cornick and Helgerson conducted an experimental study to observe the transmission of STEC O157:H7 among pigs (Cornick and Helgerson, 2004). The 3-monthold pigs were inoculated with a STEC O157:H7 strain that originated from a human outbreak, via addition of the organisms added to their feed. Moreover, they were interested in examining the effect of two different housing conditions on STEC O157:H7 shedding level and duration. In this housing experiment, a STEC strain of bovine origin was inoculated in conjunction with the STEC strain of human origin. One group of pigs was housed individually on decks with feed provided from a trough, while the other groups of pigs were housed two per pen with feed given on the cement floors. Transmission of STEC O157:H7 was observed from infected donor pigs to naïve pigs, which were housed in the same pen. Fecal shedding of STEC O157:H7 was observed in exposed naïve pigs for at least two weeks after exposure. In addition, the level and duration of STEC O157:H7 shedding was not significantly affected by different housing conditions.

The above experimental study (Cornick and Helgerson, 2004) supported a previous study (Booher et al., 2002), suggesting that shedding of STEC is dose-dependent and that swine are biologically competent hosts for STEC O157:H7. Additionally, results of this study (Cornick and Helgerson, 2004) indicated that STEC O157:H7 infection may be maintained in the swine population and that transmission readily occurs between animals. In another subsequent study by the same research group, STEC O157:H7 was recovered not only from pigs housed close to the infected donor in the adjacent pen (nose-to-nose contact), but also from naïve pigs housed in pens apart from the infected donor (Cornick and Vukhac, 2008). The isolation of the experimental bacterial strain in the air samples provided further evidence to support the hypothesis that contaminated aerosols are a means of indirect STEC O157:H7 transmission among pigs.

Antibiotic-free feed was provided in the above animal model studies. However, in most conventional swine production systems, at least in the USA, feed with antimicrobials is commonly used. Thus, the effect of antimicrobials in feed on STEC O157:H7 shedding was also examined (Cornick, 2010). A number of frequently used antimicrobials for growth promotion in US swine production were selected for this study, namely bacitracin methylene disalicylate, chlortetracycline, and tylosin. Three groups of young adult pigs were given feed with each of the three selected antimicrobials, and another group of control pigs was fed with antimicrobial-free feed. A STEC O157:H7 strain from a human outbreak in Washington State in the USA (Griffin et al., 1988) was orally inoculated at a dose of 107 CFU per strain per animal. One month after inoculation, the numbers of pigs that shed STEC O157:H7 and levels of STEC O157:H7 shedding were significantly lower in two groups given feed with tylosin and chlortetracycline compared with the control group. However, no significant differences were found in the infection levels and numbers of pigs that shed STEC O157:H7 between the bacitracin and the control groups. Interestingly, a more recent study by Wells et al., (2012) reported the numbers of pigs shedding STEC O26, O103, and O145 did not significantly differ between antimicrobial and control groups. More research is needed to evaluate the effect of sub-therapeutic doses of antimicrobials in feed on STEC shedding.

Future directions

Swine are not viewed as an important STEC reservoir given the rare known incidence of cases of severe human illness associated with STEC of swine origin. Nevertheless, the association between swine STEC and human illnesses needs to be further investigated. Pork products and feral swine have been associated with a number of STEC outbreaks. STEC causes edema disease in swine. However, STEC can be also isolated from clinically healthy pigs at rates occasionally higher than those for cattle. In addition, animal model studies suggested that swine are biologically competent for colonization and for shedding of STEC for at least 2 months after inoculation.

The increasing surveillance of non-O157 STEC infections has raised the awareness non-O157 STEC (Law, 2000; Bettelheim, 2007; Gyles, 2007; Henderson, 2008; CDC, 2012). In the USA, six non-O157 STEC serogroups, namely O26, O103, O111, O121, O45, and O145, were recently classified as adulterants, similar to O157, in raw, non-intact beef product (FSIS, 2011). Non-O157 serogroups, namely O26, O103, O145, O111, and O91, were also identified as the major public health concerns in Europe (EFSA, 2009). Some of the non-O157 STEC strains were highly virulent and carried virulence gene profiles that were rarely reported in the previous studies. For example, the STEC O104:H4 strain involved in a large-scale outbreak in 2011 in Germany was an enteroaggregative E. coli that carried genes typical of this pathogenic E. coli group, but that also carried the stx2 gene (Bielaszewska et al., 2011). Most STEC strains detected in clinically healthy swine were non-O157 STEC (Fratamico et al., 2008). However, there is still very limited information about swine STEC.

Based on the increasing role of non-O157 STEC in human illnesses, the high prevalence and limited epidemiologic investigation of STEC in swine, we recommend further research to elucidate the unclear association between swine STEC and human illness. This will serve public health through determining whether swine are an important reservoir for STEC infection in people. If the evidence indicates swine are an important reservoir, efforts can be directed at control of this pathogen in this species, and, if swine ultimately are determined to not be an important reservoir, public health resources can be directed away from swine and toward further understanding of the epidemiology of STEC, particularly non-O157 serotypes.

References

  1. Ateba CN, Mbewe M. Detection of Escherichia coli O157:H7 virulence genes in isolates from beef, pork, water, human and animal species in the northwest province, South Africa: public health implications. Research in Microbiology. 2011;162:240–248. doi: 10.1016/j.resmic.2010.11.008. [DOI] [PubMed] [Google Scholar]
  2. Baker DR, Moxley RA, Steele MB, LeJeune JT, Christopher-Hennings J, Chen DG, Hardwidge PR, Francis DH. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle. Applied and Environmental Microbiology. 2007;73:7338–7346. doi: 10.1128/AEM.00755-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrett TJ, Lior H, Green JH, Khakhria R, Wells JG, Bell BP, Greene KD, Lewis J, Griffin PM. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. Journal of Clinical Microbiology. 1994;32:3013–3017. doi: 10.1128/jcm.32.12.3013-3017.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bertschinger HU, Gyles CL. Oedema disease of pigs. In: Gyles CL, editor. Escherichia coli in Doemstic Animals and Humans. Wallingford, UK: CAB International; 1994. pp. 193–219. [Google Scholar]
  5. Bettelheim KA. The non-O157 Shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens. Critical Reviews in Microbiology. 2007;33:67–87. doi: 10.1080/10408410601172172. [DOI] [PubMed] [Google Scholar]
  6. Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. Journal of Clinical Microbiology. 2004;42:1099–1108. doi: 10.1128/JCM.42.3.1099-1108.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beutin L, Miko A, Krause G, Pries K, Haby S, Steege K, Albrecht N. Identification of human-pathogenic strains of Shiga toxin-producing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes. Applied and Environmental Microbiology. 2007;73:4769–4775. doi: 10.1128/AEM.00873-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beutin L, Kruger U, Krause G, Miko A, Martin A, Strauch E. Evaluation of major types of Shiga toxin 2e-producing Escherichia coli bacteria present in food, pigs, and the environment as potential pathogens for humans. Applied and Environmental Microbiology. 2008;74:4806–4816. doi: 10.1128/AEM.00623-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bielaszewska M, Mellmann A, Zhang W, Kock R, Fruth A, Bauwens A, Peters G, Karch H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infectious Diseases. 2011;11:671–676. doi: 10.1016/S1473-3099(11)70165-7. [DOI] [PubMed] [Google Scholar]
  10. Bonardi S, Brindani F, Pizzin G, Lucidi L, D’Incau M, Liebana E, Morabito S. Detection of Salmonella spp., Yersinia enterocolitica and verocytotoxin-producing Escherichia coli O157 in pigs at slaughter in Italy. International Journal of Food Microbiology. 2003;85:101–110. doi: 10.1016/s0168-1605(02)00504-4. [DOI] [PubMed] [Google Scholar]
  11. Booher SL, Cornick NA, Moon HW. Persistence of Escherichia coli O157: H7 in experimentally infected swine. Veterinary Microbiology. 2002;89:69–81. doi: 10.1016/s0378-1135(02)00176-1. [DOI] [PubMed] [Google Scholar]
  12. Borges CA, Beraldo LG, Maluta RP, Cardozo MV, Guth BE, Rigobelo EC, de Avila FA. Shiga toxigenic and atypical enteropathogenic Escherichia coli in the feces and carcasses of slaughtered pigs. Foodborne Pathogens and Disease. 2012;9:1119–1125. doi: 10.1089/fpd.2012.1206. [DOI] [PubMed] [Google Scholar]
  13. Borie C, Monreal Z, Guerrero P, Sanchez ML, Martinez J, Arellano TM, Prado V. Prevalence and characterization of enterohaemorrhagic Escherichia coli isoated from healthy cattle and pigs slaughtered in Santiago, Chile. Archivos De Medicina Veterinaria. 1997;29:205–212. [Google Scholar]
  14. Botteldoorn N, Heyndrickx M, Rijpens N, Herman L. Detection and characterization of verotoxigenic Escherichia coli by a VTEC/EHEC multiplex PCR in porcine faeces and pig carcass swabs. Research in Microbiology. 2003;154:97–104. doi: 10.1016/S0923-2508(03)00028-7. [DOI] [PubMed] [Google Scholar]
  15. Brooks HJ, Mollison BD, Bettelheim KA, Matejka K, Paterson KA, Ward VK. Occurrence and virulence factors of non-O157 Shiga toxin-producing Escherichia coli in retail meat in Dunedin, New Zealand. Letters in Applied Microbiology. 2001;32:118–122. doi: 10.1046/j.1472-765x.2001.00868.x. [DOI] [PubMed] [Google Scholar]
  16. Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiology. 2011;11:142. doi: 10.1186/1471-2180-11-142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bush E. U.S. swine herd appears free of Escherichia coli O157: H7. Food Safety Digest. 1997 Jan-Feb;:4. [Google Scholar]
  18. Carter AO, Borczyk AA, Carlson JA, Harvey B, Hockin JC, Karmali MA, Krishnan C, Korn DA, Lior H. A severe outbreak of Escherichia coli O157: H7 - associated hemorrhagic colitis in a nursing home. New England Journal of Medicine. 1987;317:1496–1500. doi: 10.1056/NEJM198712103172403. [DOI] [PubMed] [Google Scholar]
  19. CDC. Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami - Washington and California, 1994. Morbidity and Mortality Weekly Report. 1995a;44:157–160. [PubMed] [Google Scholar]
  20. CDC. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111: NM-South Australia, 1995. Morbidity and Mortality Weekly Report. 1995b;44:550–558. [PubMed] [Google Scholar]
  21. CDC. [Last accessed January 31, 2013];National Shiga toxin-producing Escherichia coli (STEC) surveillance annual summary, 2009. 2012 [Available online at http://www.cdc.gov/ncezid/dfwed/PDFs/national-stec-surv-summ-2009-508c.pdf]
  22. Chapman TA, Wu XY, Barchia I, Bettelheim KA, Driesen S, Trott D, Wilson M, Chin JJ. Comparison of virulence gene profiles of Escherichia coli strains isolated from healthy and diarrheic swine. Applied and Environmental Microbiology. 2006;72:4782–795. doi: 10.1128/AEM.02885-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Cobbold R, Desmarchelier P. A longitudinal study of Shiga-toxigenic Escherichia coli (STEC) prevalence in three Australian diary herds. Veterinary Microbiology. 2000;71:125–137. doi: 10.1016/s0378-1135(99)00173-x. [DOI] [PubMed] [Google Scholar]
  24. Cobbold R, Desmarchelier P. Characterisation and clonal relationships of Shiga-toxigenic Escherichia coli (STEC) isolated from Australian dairy cattle. Veterinary Microbiology. 2001;79:323–335. doi: 10.1016/s0378-1135(00)00366-7. [DOI] [PubMed] [Google Scholar]
  25. Conedera G, Mattiazzi E, Russo F, Chiesa E, Scorzato I, Grandesso S, Bessegato A, Fioravanti A, Caprioli A. A family outbreak of Escherichia coli O157 haemorrhagic colitis caused by pork meat salami. Epidemiology and Infection. 2007;135:311–314. doi: 10.1017/S0950268806006807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cornick NA. Tylosin and chlorotetracycline decrease the duration of fecal shedding of E. coli O157: H7 by swine. Veterinary Microbiology. 2010;143:417–419. doi: 10.1016/j.vetmic.2009.11.005. [DOI] [PubMed] [Google Scholar]
  27. Cornick NA, Helgerson AF. Transmission and infectious dose of Escherichia coli O157: H7 in swine. Applied and Environmental Microbiology. 2004;70:5331–5335. doi: 10.1128/AEM.70.9.5331-5335.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Cornick NA, Vukhac H. Indirect transmission of Escherichia coli O157: H7 occurs readily among swine but not among sheep. Applied and Environmental Microbiology. 2008;74:2488–2491. doi: 10.1128/AEM.02897-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Cornick NA, Booher SL, Moon HW. Intimin facilitates colonization by Escherichia coli O157: H7 in adult ruminants. Infection and Immunity. 2002;70:2704–2707. doi: 10.1128/IAI.70.5.2704-2707.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Cray WC, Jr, Moon HW. Experimental infection of calves and adult cattle with Escherichia coli O157: H7. Applied and Environmental Microbiology. 1995;61:1586–1590. doi: 10.1128/aem.61.4.1586-1590.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dean-Nystrom EA, Bosworth BT, Cray WC, Jr, Moon HW. Pathogenicity of Escherichia coli O157: H7 in the intestines of neonatal calves. Infection and Immunity. 1997;65:1842–1848. doi: 10.1128/iai.65.5.1842-1848.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Dean-Nystrom EA, Melton-Celsa AR, Pohlenz JF, Moon HW, O’Brien AD. Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs. Infection and Immunity. 2003;71:6526–6533. doi: 10.1128/IAI.71.11.6526-6533.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. DeGrandis S, Law H, Brunton J, Gyles C, Lingwood CA. Globotetraosylceramide is recognized by the pig edema disease toxin. Journal of Biological Chemistry. 1989;264:12520–12525. [PubMed] [Google Scholar]
  34. Diekema DJ, Barr J, Boyken LD, Buschelman BJ, Jones RN, Pfaller MA, Herwaldt LA. A cluster of serious Escherichia coli infections in a neonatal intensive-care unit. Infection Control and Hospital Epidemiology. 1997;18:774–776. doi: 10.1086/647536. [DOI] [PubMed] [Google Scholar]
  35. Dohoo I, Martin W, Stryhn H. Veterinary Epidemiologic Research. 2nd edn. Charlottetown, Prince Edward Island, Canada: VER Inc.; 2010. Introduction to observational studies; pp. 151–162. [Google Scholar]
  36. Doyle MP, Archer J, Kaspar CW, Weiss R. [Last accessed February 10, 2013];Human illness casued by E. coli O157:H7 from food and non-food sources. 2006 [Available online at http://fri.wisc.edu/docs/pdf/FRIBrief_EcoliO157H7humanillness.pdf]
  37. Durso LM, Reynolds K, Bauer N, Jr, Keen JE. Shiga-toxigenic Escherichia coli O157: H7 infections among livestock exhibitors and visitors at a Texas County Fair. Vector Borne and Zoonotic Diseases. 2005;5:193–201. doi: 10.1089/vbz.2005.5.193. [DOI] [PubMed] [Google Scholar]
  38. EFSA. Technical specifications for the monitoring and reporting of verotoxigenic Escherichia coli (VTEC) on animals and food (VTEC surveys on animals and food) EFSA Journal. 2009;7:1366. [Google Scholar]
  39. Eriksson E, Nerbrink E, Borch E, Aspan A, Gunnarsson A. Verocytotoxin-producing Escherichia coli O157: H7 in the Swedish pig population. Veterinary Record. 2003;152:712–717. doi: 10.1136/vr.152.23.712. [DOI] [PubMed] [Google Scholar]
  40. Fairbrother JM, Gyles CL. Colibacillosis. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Diseases of Swine. 10th edn. Hoboken, NJ: John Wiley & Sons, Inc.; 2012. pp. 723–747. [Google Scholar]
  41. Feder I, Wallace FM, Gray JT, Fratamico P, Fedorka-Cray PJ, Pearce RA, Call JE, Perrine R, Luchansky JB. Isolation of Escherichia coli O157: H7 from intact colon fecal samples of swine. Emerging Infectious Diseases. 2003;9:380–383. doi: 10.3201/eid0903.020350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Feder I, Gray JT, Pearce RA, Fratamico PM, Bush E, Porto-Fett A, Wallace FM, Fedorka-Cray PJ, Luchansky JB. Testing of swine feces obtained through the National Animal Health Monitoring System’s Swine 2000 study for the presence of Escherichia coli O157: YU. Journal of Food Protection. 2007;70:1489–1492. doi: 10.4315/0362-028x-70.6.1489. [DOI] [PubMed] [Google Scholar]
  43. Feng PC, Jinneman K, Scheutz F, Monday SR. Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes. Applied and Environmental Microbiology. 2011;77:6699–6702. doi: 10.1128/AEM.00370-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Franke S, Harmsen D, Caprioli A, Pierard D, Wieler LH, Karch H. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin. Journal of Clinical Microbiology. 1995;33:3174–3178. doi: 10.1128/jcm.33.12.3174-3178.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Fratamico PM, Bagi LK, Bush EJ, Solow BT. Prevalence and characterization of Shiga toxin-producing Escherichia coli in swine feces recovered in the National Animal Health Monitoring System’s Swine 2000 study. Applied and Environmental Microbiology. 2004;70:7173–7178. doi: 10.1128/AEM.70.12.7173-7178.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Fratamico PM, Bhagwat AA, Injaian L, Fedorka-Cray PJ. Characterization of Shiga toxin-producing Escherichia coli strains isolated from swine feces. Foodborne Pathogen and Disease. 2008;5:827–838. doi: 10.1089/fpd.2008.0147. [DOI] [PubMed] [Google Scholar]
  47. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. Journal of Infectious Diseases. 2002;185:74–84. doi: 10.1086/338115. [DOI] [PubMed] [Google Scholar]
  48. FSIS. USDA Food Safety and Inspection Service. Shiga toxin-producing Escherichia coli in certain raw beef products. Federal Register. 2011;76:58157–58165. [Google Scholar]
  49. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157: H7, other entero-hemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiologic Reviews. 1991;13:60–98. doi: 10.1093/oxfordjournals.epirev.a036079. [DOI] [PubMed] [Google Scholar]
  50. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA. Illnesses associated with Escherichia coli O157: H7 infections. A broad clinical spectrum. Annals of Internal Medicine. 1988;109:705–712. doi: 10.7326/0003-4819-109-9-705. [DOI] [PubMed] [Google Scholar]
  51. Gyles CL. Shiga toxin-producing Escherichia coli: an overview. Journal of Animal Science. 2007;85:E45–E62. doi: 10.2527/jas.2006-508. [DOI] [PubMed] [Google Scholar]
  52. Henderson H. Direct and indirect zoonotic transmission of Shiga toxin-producing Escherichia coli . Journal of the American Veterinary Medical Association. 2008;232:848–859. doi: 10.2460/javma.232.6.848. [DOI] [PubMed] [Google Scholar]
  53. Heuvelink AE, Zwartkruis-Nahuis JT, van den Biggelaar FL, van Leeuwen WJ, de Boer E. Isolation and characterization of verocytotoxin-producing Escherichia coli O157 from slaughter pigs and poultry. International Journal of Food Microbiology. 1999;52:67–75. doi: 10.1016/s0168-1605(99)00119-1. [DOI] [PubMed] [Google Scholar]
  54. Hoffmann S, Batz MB, Morris JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. Journal of Food Protection. 2012;75:1292–1302. doi: 10.4315/0362-028X.JFP-11-417. [DOI] [PubMed] [Google Scholar]
  55. Izumiya H, Terajima J, Wada A, Inagaki Y, Itoh KI, Tamura K, Watanabe H. Molecular typing of enterohemorrhagic Escherichia coli O157: H7 isolates in Japan by using pulsed-field gel electrophoresis. Journal of Clinical Microbiology. 1997;35:1675–1680. doi: 10.1128/jcm.35.7.1675-1680.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Jay MT, Cooley M, Carychao D, Wiscomb GW, Sweitzer RA, Crawford-Miksza L, Farrar JA, Lau DK, O’Connell J, Millington A, Asmundson RV, Atwill ER, Mandrell RE. Escherichia coli O157: H7 in feral swine near spinach fields and cattle, central California coast. Emerging Infectious Diseases. 2007;13:1908–1911. doi: 10.3201/eid1312.070763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Jo MY, Kim JH, Lim JH, Kang MY, Koh HB, Park YH, Yoon DY, Chae JS, Eo SK, Lee JH. Prevalence and characteristics of Escherichia coli O157 from major food animals in Korea. International Journal of Food Microbiology. 2004;95:41–49. doi: 10.1016/j.ijfoodmicro.2004.01.016. [DOI] [PubMed] [Google Scholar]
  58. Johnsen G, Wasteson Y, Heir E, Berget OI, Herikstad H. Escherichia coli O157: H7 in faeces from cattle, sheep and pigs in the southwest part of Norway during 1998 and 1999. International Journal of Food Microbiology. 2001;65:193–200. doi: 10.1016/s0168-1605(00)00518-3. [DOI] [PubMed] [Google Scholar]
  59. Jordan DM, Cornick N, Torres AG, Dean-Nystrom EA, Kaper JB, Moon HW. Long polar fimbriae contribute to colonization by Escherichia coli O157: H7 in vivo. Infection and Immunity. 2004;72:6168–6171. doi: 10.1128/IAI.72.10.6168-6171.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Jordan DM, Booher SL, Moon HW. Escherichia coli O157: H7 does not require intimin to persist in pigs. Infection and Immunity. 2005;73:1865–1867. doi: 10.1128/IAI.73.3.1865-1867.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Karmali MA. Infection by verocytotoxin-producing Escherichia coli . Clinical Microbiology Reviews. 1989;2:15–38. doi: 10.1128/cmr.2.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli . Journal of Infectious Diseases. 1985;151:775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  63. Karmali MA, Gannon V, Sargeant JM. Verocytotoxin-producing Escherichia coli (VTEC) Veterinary Microbiology. 2010;140:360–370. doi: 10.1016/j.vetmic.2009.04.011. [DOI] [PubMed] [Google Scholar]
  64. Kaspar C, Doyle ME, Archer J. [Last accessed February 10, 2013];White paper on non-O157:H7 Shiga toxin-producing E. coli from meat and non-meat sources. 2010 [Available online at http://fri.wisc.edu/docs/pdf/FRI_Brief_NonO157STEC_4_10.pdf]
  65. Kaufmann M, Zweifel C, Blanco M, Blanco JE, Blanco J, Beutin L, Stephan R. Escherichia coli O157 and non-O157 Shiga toxin-producing Escherichia coli in fecal samples of finished pigs at slaughter in Switzerland. Journal of Food Protection. 2006;69:260–266. doi: 10.4315/0362-028x-69.2.260. [DOI] [PubMed] [Google Scholar]
  66. Keen JE, Wittum TE, Dunn JR, Bono JL, Durso LM. Shiga-toxigenic Escherichia coli O157 in agricultural fair livestock, United States. Emerging Infectious Diseases. 2006;12:780–786. doi: 10.3201/eid1205.050984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Keen JE, Durso LM, Meehan TP. Isolation of Salmonella enterica and Shiga-toxigenic Escherichia coli O157 from feces of animals in public contact areas of United States zoological parks. Applied and Environmental Microbiology. 2007;73:362–365. doi: 10.1128/AEM.01563-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Kennedy CA, Lenahan M, Ryan M, Fanning S, Sheridan J, McNamara E, Carroll A, Sweeney T. Shiga toxin-producing Escherichia coli isolated from human and pig origin induce different gene expression profiles in human Caco-2 epithelial cells. Livestock Science. 2010;133:189–191. [Google Scholar]
  69. Keum HO, Kim HK, Rho SM, Moon HJ, Park SJ, Park BK. Comparative study of Clostridium perfringens, Salmonella spp. and E. coli focused on characteristics of E. coli O157 isolated from pigs of HACCP- and non-HACCP-accredited swine farms in Korea. Korean Journal of Veterinary Research. 2010;50:113–116. [Google Scholar]
  70. Kijima-Tanaka M, Ishihara K, Kojima A, Morioka A, Nagata R, Kawanishi M, Nakazawa M, Tamura Y, Takahashi T. A national surveillance of Shiga toxin-producing Escherichia coli in food-producing animals in Japan. Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health. 2005;52:230–237. doi: 10.1111/j.1439-0450.2005.00852.x. [DOI] [PubMed] [Google Scholar]
  71. Kim J, Kim S, Kwon N, Bae W, Lim J, Koo H, Kim J, Noh K, Jung W, Park K, Park Y, Kim JY, Kim SH, Kwon NH, Bae WK, Lim JY, Koo HC, Kim JM, Noh KM, Jung WK, Park KT, Park YH. Isolation and identification of Escherichia coli O157: H7 using different detection methods and molecular determination by multiplex PCR and RAPD. Journal of Veterinary Science. 2005;6:7–19. [PubMed] [Google Scholar]
  72. Kobayashi H, Ly Thi Lien K, Tran Thi P, Yamasaki S, Taniguchi T. Prevalence of pathogenic Escherichia coli in a swine breeding environment in Can Tho Province, Vietnam. Japan Agricultural Research Quarterly. 2003;37:59–63. [Google Scholar]
  73. Lanier WA, Leeper MM, Smith KE, Tillman GE, Holt KG, Gerner-Smidt P. Pulsed-field gel electrophoresis subtypes of Shiga toxin-producing Escherichia coli O157 isolated from ground beef and humans, United States, 2001–2006. Foodborne Pathogens and Disease. 2009;6:1075–1082. doi: 10.1089/fpd.2009.0269. [DOI] [PubMed] [Google Scholar]
  74. Law D. Virulence factors of Escherichia coli O157 and other Shiga toxin-producing. E. coli Journal of Applied Microbiology. 2000;88:729–745. doi: 10.1046/j.1365-2672.2000.01031.x. [DOI] [PubMed] [Google Scholar]
  75. Lenahan M, Crowley H, O’Brien SB, Byrne C, Sweeney T, Sheridan JJ. The potential use of chilling to control the growth of Enterobacteriaceae on porcine carcasses and the incidence of E. coli O157: H7 in pigs. Journal of Applied Microbiology. 2009a;106:1512–1520. doi: 10.1111/j.1365-2672.2008.04112.x. [DOI] [PubMed] [Google Scholar]
  76. Lenahan M, O’Brien SB, Byrne C, Ryan M, Kennedy CA, McNamara EB, Fanning S, Sheridan JJ, Sweeney T. Molecular characterization of Irish E. coli O157: H7 isolates of human, bovine, ovine and porcine origin. Journal of Applied Microbiology. 2009b;107:1340–1349. doi: 10.1111/j.1365-2672.2009.04320.x. [DOI] [PubMed] [Google Scholar]
  77. Leung PH, Yam WC, Ng WW, Peiris JS. The prevalence and characterization of verotoxin-producing Escherichia coli isolated from cattle and pigs in an abattoir in Hong Kong. Epidemiology and Infection. 2001;126:173–179. doi: 10.1017/s0950268801005210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Li MC, Wang F, Li F. Identification and molecular characterization of antimicrobial-resistant Shiga toxin-producing Escherichia coli isolated from retail meat products. Foodborne Pathogens and Disease. 2011;8:489–493. doi: 10.1089/fpd.2010.0688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. MacDonald DM, Fyfe M, Paccagnella A, Trinidad A, Louie K, Patrick D. Escherichia coli O157: H7 outbreak linked to salami, British Columbia, Canada, 1999. Epidemiology and Infection. 2004;132:283–289. doi: 10.1017/s0950268803001651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Martins RP, Da Silva MC, Dutra V, Nakazato L, Leite Dda S. Prevalence of enterotoxigenic and Shiga toxin-producing Escherichia coli in pigs slaughtered in Mato Grosso, Brazil. Journal of Infection in Developing Countries. 2011;5:123–127. doi: 10.3855/jidc.1217. [DOI] [PubMed] [Google Scholar]
  81. Milnes AS, Sayers AR, Stewart I, Clifton-Hadley FA, Davies RH, Newell DG, Cook AJ, Evans SJ, Smith RP, Paiba GA. Factors related to the carriage of Verocytotoxigenic E. coli, Salmonella, thermophilic Campylobacter and Yersinia enterocolitica in cattle, sheep and pigs at slaughter. Epidemiology and Infection. 2009;137:1135–1148. doi: 10.1017/S095026880900199X. [DOI] [PubMed] [Google Scholar]
  82. Muniesa M, Recktenwald J, Bielaszewska M, Karch H, Schmidt H. Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infection and Immunity. 2000;68:4850–4855. doi: 10.1128/iai.68.9.4850-4855.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Nakazawa M, Akiba M. Swine as a potential reservoir of Shiga toxin-producing Escherichia coli O157: H7 in Japan. Emerging Infectious Diseases. 1999;5:833–834. doi: 10.3201/eid0506.990618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli . Clinical Microbiology Reviews. 1998;11:142–201. doi: 10.1128/cmr.11.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Oporto B, Esteban JI, Aduriz G, Juste RA, Hurtado A. Escherichia coli O157: H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain. Zoonoses Public Health. 2008;55:73–81. doi: 10.1111/j.1863-2378.2007.01080.x. [DOI] [PubMed] [Google Scholar]
  86. Osek J, Gallien P. Molecular analysis of Escherichia coli O157 strains isolated from cattle and pigs by the use of PCR and pulsed-field gel electrophoresis methods. Veterinarni Medicina. 2002;47:149–158. [Google Scholar]
  87. Oteiza JM, Chinen I, Miliwebsky E, Rivas M. Isolation and characterization of Shiga toxin-producing Escherichia coli from precooked sausages (morcillas) Food Microbiology. 2006;23:283–288. doi: 10.1016/j.fm.2005.04.003. [DOI] [PubMed] [Google Scholar]
  88. Paton AW, Ratcliff RM, Doyle RM, Seymour-Murray J, Davos D, Lanser JA, Paton JC. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli . Journal of Clinical Microbiology. 1996;34:1622–1627. doi: 10.1128/jcm.34.7.1622-1627.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Pierard D, Huyghens L, Lauwers S, Lior H. Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin. Lancet. 1991;338:762. doi: 10.1016/0140-6736(91)91487-f. [DOI] [PubMed] [Google Scholar]
  90. Pinaka O, Pournaras S, Mouchtouri V, Plakokefalos E, Katsiaflaka A, Kolokythopoulou F, Barboutsi E, Bitsolas N, Hadjichristodoulou C. Shiga toxin-producing Escherichia coli in Central Greece: prevalence and virulence genes of O157: H7 and non-O157 in animal feces, vegetables, and humans. European Journal of Clinical Microbiology and Infectious Diseases. 2013;32:1401–1408. doi: 10.1007/s10096-013-1889-6. [DOI] [PubMed] [Google Scholar]
  91. Pritchard GC, Smith R, Ellis-Iversen J, Cheasty T, Willshaw GA. Verocytotoxigenic Escherichia coli O157 in animals on public amenity premises in England and Wales, 1997 to 2007. Veterinary Record. 2009;164:545–549. doi: 10.1136/vr.164.18.545. [DOI] [PubMed] [Google Scholar]
  92. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. Epidemiology of Escherichia coli O157: H7 outbreaks, United States, 1982–2002. Emerging Infectious Diseases. 2005;11:603–609. doi: 10.3201/eid1104.040739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Rios M, Prado V, Trucksis M, Arellano C, Borie C, Alexandre M, Fica A, Levine MM. Clonal diversity of Chilean isolates of enterohemorrhagic Escherichia coli from patients with hemolytic-uremic syndrome, asymptomatic subjects, animal reservoirs, and food products. Journal of Clinical Microbiology. 1999;37:778–781. doi: 10.1128/jcm.37.3.778-781.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN. Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiology and Infection. 1993;110:9–16. doi: 10.1017/s0950268800050627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Samadpour M. Molecular epidemiology of Escherichia coli O157: H7 by restriction fragment length polymorphism using Shiga-like toxin genes. Journal of Clinical Microbiology. 1995;33:2150–2154. doi: 10.1128/jcm.33.8.2150-2154.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Samadpour M, Ongerth JE, Liston J, Tran N, Nguyen D, Whittam TS, Wilson RA, Tarr PI. Occurrence of Shiga-like toxin-producing Escherichia coli in retail fresh seafood, beef, lamb, pork, and poultry from grocery stores in Seattle, Washington. Applied and Environmental Microbiology. 1994;60:1038–1040. doi: 10.1128/aem.60.3.1038-1040.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Sánchez S, Martínez R, García A, Vidal D, Blanco J, Blanco M, Blanco JE, Mora A, Herrera-León S, Echeita A. Detection and characterisation of O157: H7 and non-O157 Shiga toxin-producing Escherichia coli in wild boars. Veterinary Microbiology. 2010;143:420–423. doi: 10.1016/j.vetmic.2009.11.016. [DOI] [PubMed] [Google Scholar]
  98. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne illness acquired in the United States - major pathogens. Emerging Infectious Diseases. 2011;17:7–15. doi: 10.3201/eid1701.P11101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Sheoran AS, Chapman-Bonofiglio S, Harvey BR, Mukherjee J, Georgiou G, Donohue-Rolfe A, Tzipori S. Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157: H7 prevents fatal systemic complications. Infection and Immunity. 2005;73:4607–613. doi: 10.1128/IAI.73.8.4607-4613.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Shringi S, Garcia A, Lahmers KK, Potter KA, Muthupalani S, Swennes AG, Hovde CJ, Call DR, Fox JG, Besser TE. Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157: H7 genotypes in piglet and Dutch belted rabbit models. Infection and Immunity. 2012;80:369–380. doi: 10.1128/IAI.05470-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Singer RS, Sischo WM, Carpenter TE. Exploration of biases that affect the interpretation of restriction fragment patterns produced by pulsed-field gel electrophoresis. Journal of Clinical Microbiology. 2004;42:5502–5511. doi: 10.1128/JCM.42.12.5502-5511.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Slanec T, Fruth A, Creuzburg K, Schmidt H. Molecular analysis of virulence profiles and Shiga toxin genes in food-borne Shiga toxin-producing Escherichia coli . Applied and Environmental Microbiology. 2009;75:6187–6197. doi: 10.1128/AEM.00874-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Sonntag AK, Bielaszewska M, Mellmann A, Dierksen N, Schierack P, Wieler LH, Schmidt MA, Karch H. Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Applied and Environmental Microbiology. 2005;71:8855–8863. doi: 10.1128/AEM.71.12.8855-8863.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Spika JS, Parsons JE, Nordenberg D, Wells JG, Gunn RA, Blake PA. Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157: H7 in a day care center. Journal of Pediatrics. 1986;109:287–291. doi: 10.1016/s0022-3476(86)80386-9. [DOI] [PubMed] [Google Scholar]
  105. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. The lancet. 2005;365:1073–1086. doi: 10.1016/S0140-6736(05)71144-2. [DOI] [PubMed] [Google Scholar]
  106. Thomas A, Cheasty T, Chart H, Rowe B. Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101: H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome. European Journal of Clinical Microbiology and Infectious Diseases. 1994;13:1074–1076. doi: 10.1007/BF02111832. [DOI] [PubMed] [Google Scholar]
  107. Trotz-Williams LA, Mercer NJ, Walters JM, Maki AM, Johnson RP. Pork implicated in a Shiga toxin-producing Escherichia coli O157: H7 outbreak in Ontario, Canada. Canadian Journal of Public Health. Revue Canadienne de Sante Publique. 2012;103:e322–e326. doi: 10.1007/BF03404434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Varma JK, Greene KD, Reller ME, DeLong SM, Trottier J, Nowicki SF, DiOrio M, Koch EM, Bannerman TL, York ST, Lambert-Fair MA, Wells JG, Mead PS. An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. The Journal of American Medical Association. 2003;290:2709–2712. doi: 10.1001/jama.290.20.2709. [DOI] [PubMed] [Google Scholar]
  109. Vernozy-Rozand C, Montet MP, Bertin Y, Trably F, Girardeau JP, Martin C, Livrelli V, Beutin L. Serotyping, stx2 subtyping, and characterization of the locus of enterocyte effacement island of Shiga toxin-producing Escherichia coli and E. coli O157: H7 strains isolated from the environment in France. Applied and Environmental Microbiology. 2004;70:2556–2559. doi: 10.1128/AEM.70.4.2556-2559.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Wahlstrom H, Tysen E, Olsson Engvall E, Brandstrom B, Eriksson E, Morner T, Vagsholm I. Survey of Campylobacter species, VTEC O157 and Salmonella species in Swedish wildlife. Veterinary Record. 2003;153:74–80. doi: 10.1136/vr.153.3.74. [DOI] [PubMed] [Google Scholar]
  111. Wells JE, Kalchayanand N, Berry ED, Oliver WT. Effects of antimicrobials fed as dietary growth promoters on fecal shedding of Campylobacter, Salmonella, and Shiga-toxin producing Escherichia coli in swine. Journal of Applied Microbiology. 2012;114:318–328. doi: 10.1111/jam.12065. [DOI] [PubMed] [Google Scholar]
  112. Williams DM, Sreedhar SS, Mickell JJ, Chan JC. Acute kidney failure: a pediatric experience over 20 years. Archives of Pediatrics and Adolescent Medicine. 2002;156:893–900. doi: 10.1001/archpedi.156.9.893. [DOI] [PubMed] [Google Scholar]
  113. Williams RC, Isaacs S, Decou ML, Richardson EA, Buffett MC, Slinger RW, Brodsky MH, Ciebin BW, Ellis A, Hockin J. Illness outbreak associated with Escherichia coli O157: H7 in Genoa salami. E. coli O157: H7 Working Group. Canadian Medical Association Journal. 2000;162:1409–1413. [PMC free article] [PubMed] [Google Scholar]
  114. Xia X, Meng J, McDermott PF, Ayers S, Blickenstaff K, Tran TT, Abbott J, Zheng J, Zhao S. Presence and characterization of Shiga toxin-producing Escherichia coli and other potentially diarrheagenic E. coli strains in retail meats. Applied and Environmental Microbiology. 2010;76:1709–1717. doi: 10.1128/AEM.01968-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Yan Y, Shi Y, Cao D, Meng X, Xia L, Sun J. Prevalence of Stx phages in environments of a pig farm and lysogenic infection of the field E. coli O157 isolates with a recombinant converting phage. Current Microbiology. 2011;62:458–464. doi: 10.1007/s00284-010-9729-8. [DOI] [PubMed] [Google Scholar]
  116. Zweifel C, Schumacher S, Beutin L, Blanco J, Stephan R. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter. Veterinary Microbiology. 2006;117:328–332. doi: 10.1016/j.vetmic.2006.06.017. [DOI] [PubMed] [Google Scholar]

RESOURCES